Mobile Site ›
Print Friendly View

Test ID: NMOCC    
Neuromyelitis Optica (NMO)/Aquaporin-4-IgG Cell-Binding Assay, CSF

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Diagnosis of a neuromyelitis optica spectrum disorder (NMOSD)

 

Distinguishing NMOSD from multiple sclerosis early in the course of disease

Method Name A short description of the method used to perform the test

Cell-Binding Assay (CBA) detects IgG specific for AQP4 (M1 isoform) by Indirect Immunofluorescence (IFA)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

NMO/AQP4-IgG CBA, CSF

Aliases Lists additional common names for a test, as an aid in searching

AQP
AQP4 Devic Disease Devic's Antibody
NMO (Neuromyelitis Optica)
NMO-IgG
Optic Neuritis Antibody
Optic-Spinal MS Antibody
Transverse Myelitis Antibody
Vision Loss Antibody